TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15583768

Group type: EXPERIMENTAL
Intervention: Kangaroo Mother Care
Number of subjects: 0
Study: 11176084

Group type: EXPERIMENTAL
Intervention: Intravenous fentanyl at a target plasma concentration of 2.5 ng/ml
Number of subjects: 8

Group type: COMPARATOR
Intervention: Epidural analgesia using ropivacaine alone
Number of subjects: 8

Group type: COMPARATOR
Intervention: Epidural analgesia using ropivacaine in combination with 2 microg/ml fentanyl
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control day (no opioid or epidural analgesia)
Number of subjects: 8
Study: 9037222

Group type: EXPERIMENTAL
Intervention: Cortisol (perioperative injections)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Saline solution (perioperative injections)
Number of subjects: 18
Study: 7880205

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (rHuEPO)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3305671

Group type: EXPERIMENTAL
Intervention: Regular replacement of low water content hydrogel lenses
Number of subjects: 48

Group type: COMPARATOR
Intervention: Non-replacement of low water content hydrogel lenses
Number of subjects: 48
Study: 29275147

Group type: EXPERIMENTAL
Intervention: Thiazolidinediones (TZDs)
Number of subjects: 2856
Study: 27881184

Group type: EXPERIMENTAL
Intervention: Stereotactic radiotherapy (SRT) 16 Gy
Number of subjects: 411

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 411
Study: 24405160

Group type: EXPERIMENTAL
Intervention: Tailored employment intervention
Number of subjects: 500
Study: 22866937

Group type: EXPERIMENTAL
Intervention: Oat group (100 grams of instant oat cereal daily)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Control group (100 grams of wheat flour-based noodles daily)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Oat group
Number of subjects: 166

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 166
Study: 20339124

Group type: COMPARATOR
Intervention: Emergency medical services use by Mexican Americans
Number of subjects: 1134

Group type: COMPARATOR
Intervention: Time to hospital arrival within 3 hours by sex
Number of subjects: 1134

Group type: COMPARATOR
Intervention: Language preference
Number of subjects: 1134
Study: 18447136

Group type: EXPERIMENTAL
Intervention: Dpt allergen extract
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Dpt allergen plus mixed respiratory bacterial extracts
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: MRB extract only
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 16314625

Group type: EXPERIMENTAL
Intervention: Prophylactic oophorectomy
Number of subjects: 98

Group type: COMPARATOR
Intervention: Intact ovaries (Control)
Number of subjects: 98
Study: 12576820

Group type: EXPERIMENTAL
Intervention: Compact Flex Articulating Linear Cutter (stapling device)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Traditional suture ligation technique
Number of subjects: 70
Study: 10554483

Group type: EXPERIMENTAL
Intervention: Milrinone
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control
Number of subjects: 24
Study: 8831855

Group type: EXPERIMENTAL
Intervention: Intervention group (dietary and environmental prevention programme)
Number of subjects: 359

Group type: EXPERIMENTAL
Intervention: Intervention group (breastfed infants)
Number of subjects: 359

Group type: EXPERIMENTAL
Intervention: Intervention group (hydrolysed formula)
Number of subjects: 359

Group type: COMPARATOR
Intervention: Non-intervention group (adapted formula)
Number of subjects: 359

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 359

Group type: COMPARATOR
Intervention: Non-intervention group
Number of subjects: 359
Study: 1858439

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dipyrone
Number of subjects: 0
Study: 6401636

Group type: EXPERIMENTAL
Intervention: Levonorgestrel IUDs
Number of subjects: 6000

Group type: COMPARATOR
Intervention: Nova-T IUD
Number of subjects: 6000
Study: 30659429

Group type: EXPERIMENTAL
Intervention: Physician approach
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pharmacist approach
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physician intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pharmacist intervention
Number of subjects: 0
Study: 28262413

Group type: EXPERIMENTAL
Intervention: Nivolumab 3mg/kg every 2 weeks
Number of subjects: 821

Group type: COMPARATOR
Intervention: Everolimus 10mg once daily
Number of subjects: 821

Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 821
Study: 26051564

Group type: EXPERIMENTAL
Intervention: Classical homeopathic adjunctive therapy
Number of subjects: 410

Group type: COMPARATOR
Intervention: Control group (no homeopathy)
Number of subjects: 410
Study: 23428004

Group type: EXPERIMENTAL
Intervention: Simple bifurcation stenting (provisional T approach)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Complex bifurcation stenting (crush or culotte approach)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Both simple and complex strategies
Number of subjects: 500
Study: 20652382

Group type: EXPERIMENTAL
Intervention: Breast and cervical educational program (Esperanza y Vida)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Diabetes program (control)
Number of subjects: 159
Study: 19349312

Group type: EXPERIMENTAL
Intervention: Corticotropin-releasing hormone (CRH) 1 microg/kg intravenously
Number of subjects: 100
Study: 16917445

Group type: EXPERIMENTAL
Intervention: Creatine administration (0.4 gr/kg daily for 6 months)
Number of subjects: 39
Study: 15123958

Group type: EXPERIMENTAL
Intervention: Cryotherapy for 1 hour (Group 1: first hour, Group 2: second hour)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Cryotherapy (first hour)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Cryotherapy (second hour)
Number of subjects: 16

Group type: COMPARATOR
Intervention: No cryotherapy
Number of subjects: 16
Study: 11899785

Group type: EXPERIMENTAL
Intervention: CMF plus tamoxifen
Number of subjects: 2368

Group type: COMPARATOR
Intervention: Tamoxifen alone
Number of subjects: 2368
Study: 9143434

Group type: EXPERIMENTAL
Intervention: Tacrine treatment in patients with WMLA
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Tacrine treatment in patients without WMLA
Number of subjects: 72
Study: 7968872

Group type: EXPERIMENTAL
Intervention: Nifedipine or nitrendipine (3 to 6 month treatment)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (normotensive subjects)
Number of subjects: 26
Study: 3609121

Group type: EXPERIMENTAL
Intervention: Trimethoprim suspension 3 mg/kg (fasting)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Trimethoprim suspension 3 mg/kg (with food)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Trimethoprim suspension 3 mg/kg (with food and guar)
Number of subjects: 12
Study: 30113195

Group type: EXPERIMENTAL
Intervention: Default opt-in system
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mandated choice system
Number of subjects: 0

Group type: COMPARATOR
Intervention: Default opt-out system
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mandatory donor system
Number of subjects: 0
Study: 28851413

Group type: EXPERIMENTAL
Intervention: Integrated Client Care (ICC) intervention for diabetic foot ulcers
Number of subjects: 14017

Group type: COMPARATOR
Intervention: Control for diabetic foot ulcers
Number of subjects: 14017

Group type: EXPERIMENTAL
Intervention: Integrated Client Care (ICC) intervention for pilonidal sinus
Number of subjects: 14017

Group type: COMPARATOR
Intervention: Control for pilonidal sinus
Number of subjects: 14017
Study: 26582972

Group type: EXPERIMENTAL
Intervention: A‐GPC (600 mg per day)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 23684633

Group type: EXPERIMENTAL
Intervention: Training in motivational interviewing (MI)
Number of subjects: 0
Study: 20595156

Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) levels
Number of subjects: 925

Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) tiers
Number of subjects: 925

Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT)
Number of subjects: 925
Study: 18495508

Group type: EXPERIMENTAL
Intervention: Denosumab 60mg every 6 months
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Alendronate 70mg once weekly
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 16626981

Group type: COMPARATOR
Intervention: 1 mM BMTd lotion applied twice daily for 14 days
Number of subjects: 26

Group type: COMPARATOR
Intervention: 2 mM BMTd mixture applied for 7 days
Number of subjects: 26

Group type: COMPARATOR
Intervention: 2 mM BMTd mixture applied 30 min before a cold challenge
Number of subjects: 26

Group type: COMPARATOR
Intervention: 1 mM BMTd lotion applied twice daily for 2 weeks to one eye
Number of subjects: 26

Group type: COMPARATOR
Intervention: 2 mM BMTd lotion applied to lips
Number of subjects: 26
Study: 14687475

Group type: EXPERIMENTAL
Intervention: TENS (200 micro s pulses at 100 Hz and 2 ‐ 3 times sensory threshold)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo stimulation
Number of subjects: 20
Study: 10997370

Group type: EXPERIMENTAL
Intervention: Megestrol acetate (MA) 10 mg/kg/d
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 8959999

Group type: EXPERIMENTAL
Intervention: Ultrasound (US) therapy
Number of subjects: 88

Group type: COMPARATOR
Intervention: Sham ultrasound (sham US)
Number of subjects: 88
Study: 1327697

Group type: EXPERIMENTAL
Intervention: Pre‐operative radiotherapy plus surgery (RS)
Number of subjects: 423

Group type: EXPERIMENTAL
Intervention: Surgery plus postoperative chemotherapy (SC)
Number of subjects: 423

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy plus surgery followed by postoperative chemotherapy (RSC)
Number of subjects: 423

Group type: COMPARATOR
Intervention: Surgery alone (S)
Number of subjects: 423
Study: 3906516

Group type: EXPERIMENTAL
Intervention: Intrathecal D-Ala2-D-Leu5-enkephalin (DADL)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Intrathecal morphine sulfate (MS)
Number of subjects: 10
Study: 30664397

Group type: EXPERIMENTAL
Intervention: Guided Physical Exercise and Dietary therapy (PED‐t)
Number of subjects: 15
Study: 29980181

Group type: EXPERIMENTAL
Intervention: Augmented RCT populations (including patients with one or two of the specified characteristics)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Typical RCT population (defined with typical exclusion criteria)
Number of subjects: 0
Study: 27452293

Group type: EXPERIMENTAL
Intervention: 1% sodium hypochlorite (NaOCl)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine digluconate (CHX)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide medication
Number of subjects: 49

Group type: COMPARATOR
Intervention: Both NaOCl and CHX
Number of subjects: 49
Study: 24606590

Group type: EXPERIMENTAL
Intervention: Lifestyle Intervention
Number of subjects: 300

Group type: COMPARATOR
Intervention: Health & Wellness (control) Intervention
Number of subjects: 300
Study: 21951980

Group type: EXPERIMENTAL
Intervention: Psychosocial treatment (up to 6 months)
Number of subjects: 48
Study: 20227062

Group type: EXPERIMENTAL
Intervention: Attentional bias manipulation
Number of subjects: 83
Study: 17389537

Group type: EXPERIMENTAL
Intervention: Comparative feedback reports (6 quarterly reports over 18 months)
Number of subjects: 308

Group type: COMPARATOR
Intervention: General reminders
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Telephone referrals
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Feedback practices
Number of subjects: 308

Group type: COMPARATOR
Intervention: Gentle reminder practices
Number of subjects: 308
Study: 15610946

Group type: EXPERIMENTAL
Intervention: donepezil
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: galantamine
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: rivastigmine
Number of subjects: 111

Group type: COMPARATOR
Intervention: none
Number of subjects: 111
Study: 12002555

Group type: EXPERIMENTAL
Intervention: Center- and home-based health promotion programs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recruitment methods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recruitment costs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Selection criteria and frailty status
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recruitment strategies
Number of subjects: 0
Study: 10102587

Group type: EXPERIMENTAL
Intervention: IAN block + intraosseous injection of 1.8 mL of 2% mepivacaine with 1:20,000 levonordefrin
Number of subjects: 40

Group type: COMPARATOR
Intervention: IAN block + intraosseous injection of 1.8 mL of 2% lidocaine with 1:100,000 epinephrine
Number of subjects: 40

Group type: COMPARATOR
Intervention: IAN block + mock intraosseous injection
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Heart rate increase with intraosseous injection of mepivacaine and lidocaine
Number of subjects: 40
Study: 7873114

Group type: EXPERIMENTAL
Intervention: Exercise coaching for 3 months
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no exercise coaching)
Number of subjects: 20
Study: 2116260

Group type: EXPERIMENTAL
Intervention: Pravastatin monotherapy (5 mg, 10 mg, and 20 mg twice daily)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Pravastatin with cholestyramine therapy
Number of subjects: 33
Study: 1275001

Group type: EXPERIMENTAL
Intervention: Mediation group
Number of subjects: 45

Group type: COMPARATOR
Intervention: Standard group
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45
Study: 31638882

Group type: EXPERIMENTAL
Intervention: Group Music Therapy (GMT) combined with Treatment as Usual (TAU)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU) only
Number of subjects: 60
Study: 30711463

Group type: EXPERIMENTAL
Intervention: Registered dietitian nutritionist-led telemedicine program
Number of subjects: 118

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 118
Study: 28625255

Group type: EXPERIMENTAL
Intervention: D3 treatment group (supplemented 300 kU vitamin D3)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo group (injected 1 mL physiological saline)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: D3 treatment group
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 57
Study: 27352341

Group type: EXPERIMENTAL
Intervention: Continuous sedation therapy with midazolam
Number of subjects: 104

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 104
Study: 23911266

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 452

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 452
Study: 22013734

Group type: EXPERIMENTAL
Intervention: 500 million of Lactobacillus bulgaricus and Streptococcus thermophilus per day
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo tablet (120 mg of starch)
Number of subjects: 30
Study: 19754998

Group type: EXPERIMENTAL
Intervention: Mailed toolkit including professional guidelines, BMI calculation tool, growth charts, and educational information.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no toolkit received).
Number of subjects: 0
Study: 18036708

Group type: EXPERIMENTAL
Intervention: IMVAMUNE (MVA) vaccine administered at Study Days 0 and 28 by subcutaneous or intramuscular injection
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: IMVAMUNE (MVA) vaccine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: IMVAMUNE vaccination prior to Dryvax
Number of subjects: 90

Group type: COMPARATOR
Intervention: Dryvax
Number of subjects: 90
Study: 15023585

Group type: EXPERIMENTAL
Intervention: Fluoxetine plus olanzapine (5-10 mg, mean 6.1 mg)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Fluoxetine plus placebo
Number of subjects: 44
Study: 14714042

Group type: EXPERIMENTAL
Intervention: Etanercept (25 mg twice per week subcutaneously)
Number of subjects: 71
Study: 10215295

Group type: EXPERIMENTAL
Intervention: Nonsteroidal anti-inflammatory drugs (NSAIDs)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group (not receiving NSAIDs)
Number of subjects: 88
Study: 7880782

Group type: EXPERIMENTAL
Intervention: 0.006% latanoprost given twice daily
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo given at 8 am and latanoprost at 8 pm for 3 months
Number of subjects: 50
Study: 2233599

Group type: EXPERIMENTAL
Intervention: Nitrendipine
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 27372

Group type: EXPERIMENTAL
Intervention: Camazepam
Number of subjects: 31

Group type: COMPARATOR
Intervention: Chlordiazepoxide
Number of subjects: 31
Study: 31315150

Group type: EXPERIMENTAL
Intervention: Gratitude journalling intervention (8 weeks)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard care (8 weeks)
Number of subjects: 80
Study: 31443726

Group type: COMPARATOR
Intervention: Control group (originally planned cohort)
Number of subjects: 509

Group type: COMPARATOR
Intervention: Control group (all randomized cohort)
Number of subjects: 509
Study: 28365444

Group type: EXPERIMENTAL
Intervention: Strict gluten-free diet
Number of subjects: 200

Group type: COMPARATOR
Intervention: Non-adherence to gluten-free diet
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Double-blind, placebo-controlled challenge
Number of subjects: 200
Study: 26062190

Group type: EXPERIMENTAL
Intervention: Auricular point sticking before operation combined with paracetamol and dihydrocodeine tartrate tablets, and diosmin tablets.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Paracetamol and dihydrocodeine tartrate tablets, and diosmin tablets.
Number of subjects: 80
Study: 23578667

Group type: EXPERIMENTAL
Intervention: Restriction spectrum imaging cellularity maps
Number of subjects: 12

Group type: COMPARATOR
Intervention: ADC
Number of subjects: 12

Group type: COMPARATOR
Intervention: Bevacizumab
Number of subjects: 12
Study: 21455007

Group type: EXPERIMENTAL
Intervention: Daily glycerin suppository (250 mg for 24‐27(+6) weeks subgroup or 500 mg for 28‐31(+6) weeks subgroup) for 10 days from 24 hours of age
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Daily glycerin suppository
Number of subjects: 54
Study: 18507650

Group type: EXPERIMENTAL
Intervention: 8 g/l GOS/FOS in a 9 : 1 ratio (IMMUNOFORTIS)
Number of subjects: 84

Group type: COMPARATOR
Intervention: 8 g/l maltodextrine (placebo)
Number of subjects: 84
Study: 17692729

Group type: EXPERIMENTAL
Intervention: Probiotic-prebiotic complex treatment
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (2 weeks after crossover to treatment)
Number of subjects: 25
Study: 15051746

Group type: EXPERIMENTAL
Intervention: Ximelagatran + Alcohol (0.5 g/kg for women, 0.6 g/kg for men)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Ximelagatran alone
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Ximelagatran + Alcohol
Number of subjects: 26
Study: 11429716

Group type: EXPERIMENTAL
Intervention: Oracol
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: OraSure
Number of subjects: 143

Group type: COMPARATOR
Intervention: Omni‐SAL
Number of subjects: 143
Study: 9924220

Group type: EXPERIMENTAL
Intervention: Hyperbaric bupivacaine 5 mg ml‐1
Number of subjects: 100

Group type: COMPARATOR
Intervention: Isobaric bupivacaine 5 mg ml‐1
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups (Isobaric and Hyperbaric bupivacaine)
Number of subjects: 100
Study: 7800402

Group type: COMPARATOR
Intervention: Bupivacaine (30 cc of 0.25% bupivacaine with 1:200,000 epinephrine)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Morphine (2 mg in 28 cc normal saline, total volume 30 cc)
Number of subjects: 81
Study: 30584113

Group type: EXPERIMENTAL
Intervention: Lower extremity aquatic exercise training
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Lower extremity + upper extremity and trunk aquatic exercise training
Number of subjects: 89

Group type: COMPARATOR
Intervention: Conventional therapy (control group)
Number of subjects: 89
Study: 28574180

Group type: EXPERIMENTAL
Intervention: Emulsion with Equol powder (Isoflavandiol‐E‐55‐RS®)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Emulsion with microencapsulated Equol (Vesisorb® Isoflavandiol‐E‐55‐RS®)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Emulsion with lecithin (Vesisorb® placebo)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 64
Study: 24963830

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy-based training intervention (ACTr)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Psychoeducation Training (PETr)
Number of subjects: 0
Study: 23541330

Group type: EXPERIMENTAL
Intervention: Whole Body Vibration (WBV)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Normal Gravity (NG)
Number of subjects: 14
Study: 21547878

Group type: EXPERIMENTAL
Intervention: Propofol sedation
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Propofol sedation in patients with minimal hepatic encephalopathy (MHE; n=64)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Critical flicker frequency (CFF) assessment
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: CFF in patients with CFF < 38 Hz
Number of subjects: 108
Study: 18539406

Group type: COMPARATOR
Intervention: Long-course radiotherapy (RT)
Number of subjects: 231

Group type: COMPARATOR
Intervention: Short-course radiotherapy (RT)
Number of subjects: 231
Study: 16649506

Group type: EXPERIMENTAL
Intervention: Hospital at Home
Number of subjects: 2048

Group type: COMPARATOR
Intervention: Continued care in an acute hospital
Number of subjects: 2048
Study: 15130916

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) (estrogen plus progestin)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Estrogen Replacement Therapy (ERT)
Number of subjects: 0
Study: 10757383

Group type: EXPERIMENTAL
Intervention: Laparoscopic aorto-femoral bypass grafting procedure
Number of subjects: 41

Group type: COMPARATOR
Intervention: Conventional bypass grafting procedure
Number of subjects: 41
Study: 9069481

Group type: EXPERIMENTAL
Intervention: Right sided lesions
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Left sided lesions
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 31
Study: 8379860

Group type: EXPERIMENTAL
Intervention: Iron dextran injections (5 injections spaced 4 weeks)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Iron with folic acid orally
Number of subjects: 100